Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Dexamethasone mouth wash

Next Previous
Drug Profile

Dexamethasone mouth wash

Alternative Names: Dexamethasone mouth rinse; Dexamethasone mouthwash; Dexamethasone-based mouth wash

Latest Information Update: 14 Jan 2022

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Novartis
  • Class Anti-inflammatories; Antiallergics; Antiemetics; Antihyperglycaemics; Antineoplastics; Antirheumatics; Eye disorder therapies; Fluorinated steroids; Glucocorticoids; Ketones; Non-opioid analgesics; Phosphates; Pregnadienetriols; Small molecules; Sodium compounds; Vestibular disorder therapies
  • Mechanism of Action Glucocorticoid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Stomatitis

Most Recent Events

  • 13 Jan 2021 Novartis completes the phase II BOLERO-4 trial in Breast cancer (Combination therapy, First-line therapy, Late-stage disease) in USA, Argentina, Brazil, France, Hungary, Japan, South Korea, Netherlands, Portugal, Thailand, Turkey, United Kingdom (PO) (NCT01698918)
  • 06 Sep 2017 Phase II development is ongoing in USA, Argentina and Brazil (NCT02069093) (NCT01698918)
  • 01 Mar 2016 Novartis Pharmaceuticals completes the STOPP trial in Stomatitis (Prevention) in USA (Buccal) (NCT02069093)
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top